10:35 IST
BSE
Other AnnouncementAjanta Pharma Ltd AJANTPHARM
Ajanta Pharma Other Announcement
The company submitted its quarterly shareholding pattern under Regulation 31(1)(b) for the quarter ended September 30, 2026.
ALFA Filings
Every announcement, straight from the exchange
Every Ajanta Pharma other announcement announcement on NSE and BSE, newest first, each with its own page.
Time
3 announcements
The company submitted its quarterly shareholding pattern under Regulation 31(1)(b) for the quarter ended September 30, 2026.
Ajanta Pharma submitted its Annual Secretarial Compliance Report for the year ended March 2026. This routine regulatory filing confirms adherence to SEBI listing obligations and disclosure requirements.
Ajanta Pharma's promoters have submitted a declaration under SEBI Takeover Regulations for the financial year ended March 31, 2026. The filing confirms that no new direct or indirect encumbrances were made on promoter shares during the year, other than those already disclosed.